ЛИТЕРАТУРА

Поставить закладку

Schneider D.T., Schuster A.E., Fritsch M.K. et al. Multipoint imprinting analysis indicates a common precursor cell for gonadal and nongonadal pediatric germ cell tumors // Cancer Res. – 2001. – Vol. 61, N 19. – P. 7268 – 7276.
McLaren A. Germ and somatic cell lineages in the developing gonad. Mol Cell Endocrinol. 2000;163:3-9.
Saitou M, Barton SC, Surani MA. A molecular programme for the specification of germ cell fate in mice. Nature. 2002; 418:293-300.
Scholer HR, Dressier GR, Balling R, et al. Oct-4: a germline-specific transcription factor mapping to the mouse t-complex. EMBOJ. 1990;9:2185-2195.
Hansis C, Grifo JA, Krey LC. Oct-4 expression in inner cell mass and trophectoderm of human blastocysts. Mol Hum Reprod. 2000;6:999-1004.
Pesce M, Scholer HR. Oct-4: control of totipotency and germline determination. Mol Reprod Dev. 2000;55:452-457.
Pesce M, Scholer HR. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells. 2001;19:271-278.
Rajpert-De Meyts E, Hanstein R, Jorgensen N, et al. Developmental expression of POU5F1 (OCT-3/4) in normal and dysge-netic human gonads. Hum Reprod. 2004;19:1338-1344.
Hatano SY, Tada M, Kimura H, et al. Pluripotential competence of cells associated with Nanog activity. Mech Dev. 2005;122: 67-79.
Yamaguchi S, Kimura H, Tada M, et al. Nanog expression in mouse germ cell development. Gene Expr Patterns. 2005;5: 639-646.
Payer B, Chuva de Sousa Lopes SM, Barton SC, et al. Generation of stella-GFP transgenic mice: a novel tool to study germ cell development. Genesis. 2006;44:75-83.
Buitrago W, DR. Oct-4: the almighty POUripotent regulator?) Invest Dermatol. 2007;127:260-262.
Looijenga LH, Stoop H, de Leeuw HP, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ eel tumors. Cancer Res. 2003;63:2244- 2250.
de Jong J, Stoop H, Dohle GR, et al. Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours. ] Pathol. 2005;206:242-249.
Hart AH, Hartley L, Parker K, et al. The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer. 2005;104:2092-2098.
Kersemaekers AM, Honecker F, Stoop H, et al. Identification of germ cells at risk for neoplastic transformation in gonadoblas-toma: an immunohistochemical study for OCT3/4 and TSPY Hum Pathol. 2005;36:512-521.
Cheng L, Sung MT, Cossu-Rocca P, et al. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol. 2007;211:1-9.
Rogers P.S., Olson T.A., Cullen J.W. et al. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study – Pediatric Oncology Group 9048 and Children’s Cancer Group 8891 // J Clin Oncol. – 2004. – Vol. 22, N17. – P. 3663 – 3569.
Malogolowkin M.H., Monforte H.L., Kovanlikava A. et al. Pediatric germ cell tumors / Raghavan D. (eds). Germ cell tumors. – London: BC Decker Inc Hamilton, 2003. – P. 265 – 286.
Moller H., Evans H. Epidemiology of gonadal germ cell cancer in males and females // APMIS. – 2003. – Vol. 111, N 1. – P. 43 – 46.
Canto P., Kofman-Alfaro S., Jiminez A.L. et al. Gonadoblastoma in Turner syndrome patients with nonmosaic 45,X karyotype and Y chromosome sequences // Cancer Genet Cytogenet. – 2004. – Vol. 150, N 1. – P. – 70 – 72.
Carli M., Colombatti R., Oberlin O. et al. European intergroup studies (MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors // J Clin Oncol. – 2004. – Vol. 22, N 23. – P. 4787 – 4794.
Fizazi K., Prow D.M., Do K.A. et al. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumors // Br J Cancer. – 2002. – Vol. 86, N 10. – P. 1555 – 1560.
Guven S., Basaran M., Usubutum A. et al. Management of ovarian dysgerminoma during a pregnancy complicated by preeclampsia; a case report // Eur J Gynaecol Oncol. – 2004. – Vol. 25, N 6. – P. 759 – 760.
International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancer. International Germ Cell Cancer Collaborative Group // J Clin Oncol. – 1997. – Vol. 15, N 2. – P. 594 – 603.
Dumesnil C., Gatbois E., Leverger G. Infantile choriocarcinoma: an uncommon and curable tumor // Arch Pediatr. – 2005. –Vol. 12, N 12. – P. 1721 – 1725.
Amato R.J., Ro J.Y., Ayala A.G. et al. Risk-adapted treatment for patient with clinical stage I nonseminomatous germ cell tumor of testis // Urology. – 2004. – Vol. 63, N 1. – P. 144 – 148.
Best D.H., Butz G.M., Moller K. et al. Molecular analysis of an immature ovarian teratoma with gliomatosis peritonei and recurrence suggests genetic independence of multiple tumors // Int J Oncol. – 2004. – Vol. 25, N 1. – P. 17 – 25.
Bhala N., Coleman J.M., Radstone C.R. et al. The manangement and survival of patients with advanced germ-cell tumors: improving outcome in intermediate and poor prognosis patients // Clin Oncol (R Coll Radiol). – 2004. – Vol. 16, N 1. – P. 40 – 47.
Chen Z., Robison L., Giller R. et al. Risk of childhood germ cell tumors in association with parental smoking and drinking // Cancer. – 2005. – Vol. 103, N 5. – P. 1064 – 1071.
Billmire D., Vinocur C., Rescoria F. et al. Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study // J Pediatr Surg. – 2004. – Vol. 30, N 3. – P. 424 – 429.
Cushing B., Giller R., Cullen J.W., et al. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescent with high-risk malignant germ cell tumors: a pediatric intergroup study-Pediatric Oncology Group 9049 and Children’s Cancer Group 8882 //J Clin Oncol. – 2004. – Vol. 22, N 13. – P. 2691 – 700.
O’Connor D.M., Norris H.J. The influence of grade on the outcome of stage I ovarian immature (malignant) teratomas and the reproducibility of grading // Int J Gynecol Pathol. – 1994. – Vol. 13, N 4. – P. 283 – 289.
Steeper T.A., Mukai K. Solid ovarian teratomas: an immunocytochemical study of thirteen cases with clinicopathologic correlation // Pathol Annu. – 1984. – Vol. 19, N 1. – P. 81 – 92.
Norris H.J., Zirkin H.J., Benson W.L. Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases // Cancer. – 1976. – Vol. 37, N 5. – P. 2359 – 2372.
Robboy S.J., Scully R.E. Ovarian teratoma with glial implants on the peritoneum. An analysis of 12 cases // Hum Pathol. – 1970. – Vol. 1, N 4. – P. 643 – 653.
Umekawa T., Tabata T., Tanida K. et al. Growing teratoma syndrome as an unusual cause of gliomatosis peritonei: a case report // Gynecol Oncol. – 2005. – Vol. 99, N 3. – P. 761 – 763.
Gabrys M., Blok K., Rabczynski J. et al. Gliomatosis peritonei with mature of the ovary // Ginecol Pol. – 2002. – Vol. 73, N 12. – P. 1224 – 1227.
Trabelsi A., Conan-Charlet V., Lhomme C. et al. Peritoneal glioblastoma: recurrence of ovarian immature teratoma (report of a case) // Ann Pathol. – 2002. – Vol. 22, N 2. – P. 130 – 133.
Marina N.M., Cushing B., Giller R. et al. Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: a Pediatric Oncology Group / Children’s Cancer Group Intergroup Study // J Clin Oncol. – 1999. – Vol. 17, N 7. – P. 2137 – 2145.
Harms D., Zahn S., Gobel U. et al. Pathology and molecular biology of teratomas in children and adolescence // Klin Padiatr. – 2006. – Vol. 218, N 6. – P. 296 – 302.
Schneider D.T., Calaminus G.,Koch S. et al. Epidemiologic analysis of 1,442 children and adolescents registered in the German germ cell tumor protocols // Pediatr Blood Cancer. – 2004. – Vol. 42, N2. – P. 169 – 175.
Gobel U., Calaminus G., Schneider D.T. et al. The malignant potential of teratomas in infancy and children: the MAKEI experiences in non-testicular teratoma and implications for a new protocol // Klin Padiatr. – 2006. – Vol. 218, N 6. – P. 309 – 314.
Adcock L.L., Oakley G.J. A pure brain metastasis of choriocarcinoma from a mixed germ cell tumor of ovary // Gynecol Oncol. – 1997. – Vol. 64, N 2. – P. 252 – 255.
Challis D.E., Rew K.J., Steigrad S.J. Choriocarcinoma complicated by splenic rupture: an unusual presentation // J Obstet Gynaecol Res. – 1996. – Vol 22, N 4. – P. 395 – 400.
Goswami D., Sharma K., Zutshi V. et al. Nongestational pure ovarian choriocarcinoma with contralateral teratoma // Gynecol Oncol. – 2001. – Vol. 80, N 2. – P. 262 – 266.
Smith H.O., Berwick M., Verschrraegen C.F. et al. Incidence and survival rates for female malignant germ cell tumors // Obstet Gynecol. – 2006. – Vol. 107, N 5. – P. 1075 – 1085.
Wen K.C., Hu W.M., Twu N.F. et al. Poor prognosis of intraoperative rupture of mature cystic teratoma with malignant tramsformation // Taiwan J Obstet Gynecol. – 2006.- Vol. 45, N 3. – P. 253 – 256.
Habuchi T., Kamoto T., Hara I. et al. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers // Cancer. – 2003. – Vol. 98, N 8. – P. 1635 – 1642.
Smith H.O., Berwick M., Verschrraegen C.F. et al. Incidence and survival rates for female malignant germ cell tumors // Obstet Gynecol. – 2006. – Vol. 107, N 5. – P. 1075 – 1085.
Frazier A.L., Rumcheva P., Olson T. et al. Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors: a report from the Children’s Oncology Group // Pediatr Blood Cancer. – 2008. – Vol. 50, N 4. – P. 746 – 751.
Pectasides D., Pectasides E., Kassanos D. Germ cell tumors of the ovary // Cancer Treat Rev. – 2008. – Vol. 34, N 5. – P. 427 – 441.
Poncelet C., Fauvet R., BoccaraJ. Et al. Recurrence after cystectomy for borderline ovarian tumors: results of a French multicenter study // Ann Surg Oncol. – 2006. – Vol. 13, N 4. – P. 565 – 571.
Suita S., Shono K., Tajiri T. et al. Malignant germ cell tumors: clinical characteristics, treatment and outcome. A report from the study group for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan // J Pediatr Surg. – 2002. – Vol. 37, N 12. – P. 1703 – 1706.
Odegaard E., Staff A.C., Langebrekke A. et al. Surgery of borderline tumors of the ovary: retrospective comparison of short-term outcome after laparoscopy or laparotomy // Acta Obstet Gynecol Scand. – 2007. – Vol. 86, N 5. – P. 620 – 626.
Song Y.N., Zhu L., Lang J.H. Recurrent mature ovarian teratomas: retrospective analysis of 20 cases // Zhonghua Yi Xue Za Zhi. – 2007. – Vol. 87, N 17. – P. 1184 – 1186.
Smorqick N., Barel O., Halperin R. et al. Laparoscopic removal of adnexal cysts: is it possible to decrease inadvertent intraoperative rupture rate // Am J Obstet Gynecol. – 2009. – Vol. 200, N 3. – P. 237- 240.
Salani R., Goodrich K., Song C. et al. Three cases reports of laparoscopic management of granulose cell tumor with intraoperative rupture and subsequent upstaging // J Minim Invasive Gynecol. – 2008. – Vol. 15, N 4. – P. 511 – 513.
Ishibashi M., Nakayama K., Oride A. et al. A case of PEP(BEP)-resistant ovarian disgerminoma successfully treated by VeIP therapy // Gan To Kagaku Ryoho. – 2009. – Vol. 36, N 3. – P. 513 – 517.
Sim H.G., Lange P.H., Lin D.W. Role of post-chemotherapy surgery in germ cell tumors // Urol Clin North Am. – 2007. – Vol. 34, N 2. – P. 199 – 217.
Li J., Yang W., Wu X. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients // Gynecol Oncol. – 2007. – Vol. 105, N 3. – P. 769 – 775.
Suita S., Shono K., Tajiri T. et al. Malignant germ cell tumors: clinical characteristics, treatment and outcome. A report from the study group for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan // J Pediatr Surg. – 2002. – Vol. 37, N 12. – P. 1703 – 1706.
Smith H.O., Berwick M., Verschrraegen C.F. et al. Incidence and survival rates for female malignant germ cell tumors // Obstet Gynecol. – 2006. – Vol. 107, N 5. – P. 1075 – 1085.
Aisenberg J., Hsiah K., Kataitzoglou G. et al. Bone mineral density (BMD) in long-term survivors of childhood cancer // J Pediatr Hematol Oncol . – 1998. – Vol. 20. – P. 241 – 245.
Critchley H.O. Factors of importance for implantation and after treatment for childhood cancer // Med Pediatr Oncol. – 1999. – Vol. 33, N 1. – P 9 – 14.
Hudson N.M., Greenwald C., Thompson E. et al. Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin’s disease // J Clin Oncol. – 1993. – Vol. 11. – P. 100 – 108.
O'Connor DM, Norris HJ. The influence of grade on the outcome of stage I ovarian immature (malignant) teratomas and the reproducibility of grading. Int J Gynecol Pathol. 1994;13:283-289.
Kooijman CD. Immature teratomas in children. Histopathology. 1988;12:491- 502.
Cushing B, Giller R, Ablin A, et al. Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the Pediatric Oncology Group and the Children's Cancer Group. Am J Obstet Gynecol. 1999;181:353-358.
ZhangY, Graubard BI, Longnecker MP, et al. Maternal hormone levels and perinatal characteristics: implications for testicular cancer. Ann Epidemiol. 2007;17:85-92.
Aschim EL, Grotmol T,Tretli S, HaugenTB. Is there an association between maternal weight and the risk of testicular cancer? An epidemiologic study of Norwegian data with emphasis on World War II. Int J Cancer. 2005;116:327-330.
Rasmussen F, Gunnell D, Ekbom A, et al. Birth weight, adult height, and testicular cancer: cohort study of 337,249 Swedish young men. Cancer Causes Control. 2003; 14:595-598.
Richiardi L, Askling J, Granath F, Акте О. Body size at birth and adulthood and the risk for germ-cell testicular cancer. Cancer Epidemiol Biomarkers Prev. 2003;12:669-673.
Shu XO, Nesbit ME, Buckley JD, et al. An exploratory analysis of risk factors for childhood malignant germ-cell tumors: report from the Childrens Cancer Group (Canada, United States). Cancer Causes Control. 1995;6:187-198.

Для продолжения работы требуется Регистрация

Предыдущая страница

Следующая страница